$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 7 8 9 10 11
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 234 | 468 | 234 | 0 to 234 |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 405 | 243 | 47,381 | |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 390 | 1,677 | 42,868 | |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,393 | 5,990 | 43,258 | |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.10 | 405 | 4,901 | 75,000 | 75.4 K to 75 K (-0.54 %) |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 405 | 243 | 75,405 | 75 K to 75.4 K (+0.54 %) |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.94 | 390 | 4,657 | 75,000 | 75.4 K to 75 K (-0.52 %) |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 390 | 1,677 | 75,390 | 75 K to 75.4 K (+0.52 %) |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.90 | 1,393 | 16,578 | 75,000 | 76.4 K to 75 K (-1.82 %) |
Nov 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,393 | 5,990 | 76,393 | 75 K to 76.4 K (+1.86 %) |
Nov 28 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 201 | 121 | 47,180 | |
Nov 28 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.10 | 201 | 2,432 | 75,000 | 75.2 K to 75 K (-0.27 %) |
Nov 28 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 201 | 121 | 75,201 | 75 K to 75.2 K (+0.27 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.01 | 999 | 11,997 | 2,238,667 | 2.2 M to 2.2 M (-0.04 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.02 | 1,101 | 13,232 | 2,239,666 | 2.2 M to 2.2 M (-0.05 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3 | 2 | 47,786 | |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 7 | 4 | 47,789 | |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.10 | 3 | 36 | 75,000 | 75 K to 75 K (0.00 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3 | 2 | 75,003 | 75 K to 75 K (0.00 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.10 | 7 | 85 | 75,000 | 75 K to 75 K (-0.01 %) |
Nov 21 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 7 | 4 | 75,007 | 75 K to 75 K (+0.01 %) |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 3,439 | 2,063 | 47,500 | |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 1,561 | 937 | 50,939 | |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.01 | 3,439 | 41,313 | 53,594 | 57 K to 53.6 K (-6.03 %) |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 3,439 | 2,063 | 57,033 | 53.6 K to 57 K (+6.42 %) |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.01 | 1,561 | 18,749 | 53,594 | 55.2 K to 53.6 K (-2.83 %) |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 1,561 | 937 | 55,155 | 53.6 K to 55.2 K (+2.91 %) |
Nov 20 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 11.90 | 10,000 | 119,000 | 53,594 | 63.6 K to 53.6 K (-15.72 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.95 | 2,000 | 25,900 | 53,000 | 55 K to 53 K (-3.64 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.01 | 5,833 | 70,030 | 55,000 | 60.8 K to 55 K (-9.59 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 2,000 | 24,000 | 2,240,767 | 2.2 M to 2.2 M (-0.09 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.18 | 3,400 | 41,423 | 2,242,767 | 2.2 M to 2.2 M (-0.15 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.75 | 15,000 | 191,250 | 2,246,167 | 2.3 M to 2.2 M (-0.66 %) |
Nov 16 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Gift | G | 0.00 | 18,000 | 0 | 2,261,167 | 2.3 M to 2.3 M (-0.79 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 5,000 | 3,000 | 52,500 | |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 4,300 | 2,580 | 57,500 | |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.00 | 5,000 | 60,000 | 62,500 | 67.5 K to 62.5 K (-7.41 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.02 | 4,300 | 51,697 | 67,500 | 71.8 K to 67.5 K (-5.99 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 5,000 | 3,000 | 71,800 | 66.8 K to 71.8 K (+7.49 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 4,300 | 2,580 | 66,800 | 62.5 K to 66.8 K (+6.88 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 47,796 | |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 12.10 | 3,676 | 44,480 | 75,000 | 78.7 K to 75 K (-4.67 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 78,676 | 75 K to 78.7 K (+4.90 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.01 | 15,000 | 180,161 | 2,279,167 | 2.3 M to 2.3 M (-0.65 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 12.00 | 7,500 | 90,000 | 2,294,167 | 2.3 M to 2.3 M (-0.33 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 10,000 | 20,000 | 187,500 | |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 6,029 | 12,058 | 197,500 | |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.89 | 10,000 | 118,900 | 0 | 10 K to 0 (-100.00 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.94 | 6,029 | 72,009 | 10,000 | 16 K to 10 K (-37.61 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 10,000 | 20,000 | 16,029 | 6 K to 16 K (+165.86 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 6,029 | 12,058 | 6,029 | 0 to 6 K |
Nov 07 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.83 | 2,500 | 29,572 | 85,000 | 87.5 K to 85 K (-2.86 %) |
Nov 07 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.34 | 2,500 | 28,357 | 87,500 | 90 K to 87.5 K (-2.78 %) |
Nov 08 2012 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 12.00 | 40,000 | 479,828 | 3,750,277 | 3.7 M to 3.8 M (+1.08 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 316 | 190 | 51,472 | |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 2,900 | 1,740 | 51,788 | |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 3,566 | 15,334 | 44,651 | |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 4,136 | 2,482 | 54,688 | |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 10.70 | 316 | 3,380 | 75,000 | 75.3 K to 75 K (-0.42 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 316 | 190 | 75,316 | 75 K to 75.3 K (+0.42 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.00 | 2,900 | 31,914 | 75,000 | 77.9 K to 75 K (-3.72 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 2,900 | 1,740 | 77,900 | 75 K to 77.9 K (+3.87 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 10.83 | 7,702 | 83,410 | 75,000 | 82.7 K to 75 K (-9.31 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 3,566 | 15,334 | 82,702 | 79.1 K to 82.7 K (+4.51 %) |
Oct 22 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 4,136 | 2,482 | 79,136 | 75 K to 79.1 K (+5.51 %) |
Oct 09 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.47 | 1,893 | 21,711 | 90,000 | 91.9 K to 90 K (-2.06 %) |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 3,971 | 7,942 | 203,529 | |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.89 | 3,971 | 47,216 | 0 | 4 K to 0 (-100.00 %) |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 3,971 | 7,942 | 3,971 | 0 to 4 K |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.38 | 3,107 | 35,372 | 91,893 | 95 K to 91.9 K (-3.27 %) |
Oct 03 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Sell | S | 11.53 | 15,000 | 172,955 | 2,301,667 | 2.3 M to 2.3 M (-0.65 %) |
Oct 01 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.98 | 2,100 | 25,157 | 60,833 | 62.9 K to 60.8 K (-3.34 %) |
Oct 01 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.95 | 300 | 3,586 | 62,933 | 63.2 K to 62.9 K (-0.47 %) |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 48,217 | |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 58,824 | |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.86 | 5,459 | 64,725 | 75,000 | 80.5 K to 75 K (-6.78 %) |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 80,459 | 78.7 K to 80.5 K (+2.27 %) |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 78,676 | 75 K to 78.7 K (+4.90 %) |
Sep 27 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.96 | 7,401 | 88,480 | 63,233 | 70.6 K to 63.2 K (-10.48 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.96 | 2,705 | 32,358 | 70,634 | 73.3 K to 70.6 K (-3.69 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.01 | 200 | 2,402 | 73,339 | 73.5 K to 73.3 K (-0.27 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.01 | 661 | 7,937 | 73,539 | 74.2 K to 73.5 K (-0.89 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 100 | 60 | 61,800 | |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 200 | 120 | 61,900 | |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.01 | 100 | 1,201 | 62,500 | 62.6 K to 62.5 K (-0.16 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 100 | 60 | 62,600 | 62.5 K to 62.6 K (+0.16 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.02 | 200 | 2,404 | 62,500 | 62.7 K to 62.5 K (-0.32 %) |
Sep 24 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 200 | 120 | 62,700 | 62.5 K to 62.7 K (+0.32 %) |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.05 | 800 | 9,638 | 74,200 | 75 K to 74.2 K (-1.07 %) |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | M | 0.60 | 400 | 240 | 62,100 | |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Sell | S | 12.12 | 400 | 4,849 | 62,500 | 62.9 K to 62.5 K (-0.64 %) |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Buy | M | 0.60 | 400 | 240 | 62,900 | 62.5 K to 62.9 K (+0.64 %) |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.71 | 1,200 | 14,054 | 95,000 | 96.2 K to 95 K (-1.25 %) |
Sep 19 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.92 | 3,800 | 45,286 | 96,200 | 100 K to 96.2 K (-3.80 %) |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 14.31 | 485,088 | 6,941,609 | 485,088 | |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 14.31 | 121,166 | 1,733,885 | 121,166 | |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | A | 14.31 | 110,664 | 1,583,602 | 110,664 | |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 14.31 | 123,156 | 1,762,362 | 123,156 | |
Jul 26 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | A | 14.31 | 104,289 | 1,492,376 | 104,289 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | Gupta Rishi | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 26 2012 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 14.42 | 12,500 | 180,250 | 12,500 | |
Jun 07 2012 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 12.62 | 25,000 | 315,500 | 25,000 | |
Apr 27 2012 | CCXI | ChemoCentryx, Inc. | FECZKO JOSEPH M | Director | Option Exercise | A | 15.90 | 25,000 | 397,500 | 25,000 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | A | 10.27 | 24,712 | 253,792 | 24,712 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | A | 10.27 | 22,090 | 226,864 | 22,090 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | A | 10.27 | 24,348 | 250,054 | 24,348 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | Schall Thomas J. | President and CEO | Option Exercise | A | 10.27 | 175,000 | 1,797,250 | 175,000 | |
Feb 29 2012 | CCXI | ChemoCentryx, Inc. | Bekker Petrus | SVP of Medical & Cl ... | Option Exercise | A | 10.27 | 19,632 | 201,621 | 19,632 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 10,540 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 73,793 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 427,683 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 2,994,341 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 28,723 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 201,097 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Buy | C | 0.00 | 42,166 | 0 | 1,868,088 | 1.8 M to 1.9 M (+2.31 %) |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Buy | C | 0.00 | 1,711,012 | 0 | 1,825,922 | 114.9 K to 1.8 M (+1,489.00 %) |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | PENHOET EDWARD | Director | Buy | C | 0.00 | 114,910 | 0 | 114,910 | 0 to 114.9 K |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 242,674 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,574,345 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 514,354 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 3,888,423 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 10,706 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 78,928 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 908,509 | 0 | 908,509 | 0 to 908.5 K |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,201,388 | 0 | 2,201,388 | 0 to 2.2 M |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 44,817 | 0 | 44,817 | 0 to 44.8 K |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 6,793,478 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 6,493,506 | 0 | 0 | |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 3,396,739 | 0 | 7,343,492 | 3.9 M to 7.3 M (+86.06 %) |
Feb 15 2012 | CCXI | ChemoCentryx, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 3,246,753 | 0 | 3,946,753 | 700 K to 3.9 M (+463.82 %) |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Buy | C | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Option Exercise | A | 20.00 | 150,000 | 3,000,000 | 150,000 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Option Exercise | C | 0.00 | 1,257,149 | 0 | 0 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Option Exercise | C | 0.00 | 1,223,148 | 0 | 0 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Option Exercise | C | 0.00 | 1,946,836 | 0 | 0 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Option Exercise | C | 0.00 | 5,000,000 | 0 | 0 | |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 6,235,056 | 5.7 M to 6.2 M (+8.72 %) |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Buy | C | 0.00 | 1,021,490 | 0 | 5,735,056 | 4.7 M to 5.7 M (+21.67 %) |
Feb 14 2012 | CCXI | ChemoCentryx, Inc. | TECHNE CORP /MN/ | 10% Owner | Buy | C | 0.00 | 4,713,566 | 0 | 4,713,566 | 0 to 4.7 M |
Feb 13 2012 | CCXI | ChemoCentryx, Inc. | Parker Geoffrey M. | Director | Buy | P | 10.97 | 4,600 | 50,462 | 4,600 | 0 to 4.6 K |